title: Does chocolate reduce blood pressure? A meta-analysis.
abstract: BACKGROUND
  Dark chocolate and flavanol-rich cocoa products have attracted interest as an alternative treatment option for hypertension, a known risk factor for cardiovascular disease. Previous meta-analyses concluded that cocoa-rich foods may reduce blood pressure. Recently, several additional trials have been conducted with conflicting results. Our study summarises current evidence on the effect of flavanol-rich cocoa products on blood pressure in hypertensive and normotensive individuals.
  
  
  METHODS
  We searched Medline, Cochrane and international trial registries between 1955 and 2009 for randomised controlled trials investigating the effect of cocoa as food or drink compared with placebo on systolic and diastolic blood pressure (SBP/DBP) for a minimum duration of 2 weeks. We conducted random effects meta-analysis of all studies fitting the inclusion criteria, as well as subgroup analysis by baseline blood pressure (hypertensive/normotensive). Meta-regression analysis explored the association between type of treatment, dosage, duration or baseline blood pressure and blood pressure outcome. Statistical significance was set at P < 0.05.
  
  
  RESULTS
  Fifteen trial arms of 13 assessed studies met the inclusion criteria. Pooled meta-analysis of all trials revealed a significant blood pressure-reducing effect of cocoa-chocolate compared with control (mean BP change +/- SE: SBP: -3.2 +/- 1.9 mmHg, P = 0.001; DBP: -2.0 +/- 1.3 mmHg, P = 0.003). However, subgroup meta-analysis was significant only for the hypertensive or prehypertensive subgroups (SBP: -5.0 +/- 3.0 mmHg; P = 0.0009; DBP: -2.7 +/- 2.2 mm Hg, P = 0.01), while BP was not significantly reduced in the normotensive subgroups (SBP: -1.6 +/- 2.3 mmHg, P = 0.17; DBP: -1.3 +/- 1.6 mmHg, P = 0.12). Nine trials used chocolate containing 50% to 70% cocoa compared with white chocolate or other cocoa-free controls, while six trials compared high- with low-flavanol cocoa products. Daily flavanol dosages ranged from 30 mg to 1000 mg in the active treatment groups, and interventions ran for 2 to 18 weeks. Meta-regression analysis found study design and type of control to be borderline significant but possibly indirect predictors for blood pressure outcome.
  
  
  CONCLUSIONS
  Our meta-analysis suggests that dark chocolate is superior to placebo in reducing systolic hypertension or diastolic prehypertension. Flavanol-rich chocolate did not significantly reduce mean blood pressure below 140 mmHg systolic or 80 mmHg diastolic.
authors.affiliation: Discipline of General Practice, The University of Adelaide, Adelaide, SA 5005, Australia. karin.ried@adelaide.edu.au
authors.forename: Karin
authors.initials: K
authors.lastname: Ried
authors.forename: Thomas
authors.initials: T
authors.lastname: Sullivan
authors.forename: Peter
authors.initials: P
authors.lastname: Fakler
authors.forename: Oliver R
authors.initials: OR
authors.lastname: Frank
authors.forename: Nigel P
authors.initials: NP
authors.lastname: Stocks
mesh_terms: D001794:Blood Pressure / Q000187:drug effects*; D002099:Cacao / Q000737:chemistry*; D004032:Diet; D005419:Flavonoids / Q000494:pharmacology*; D006801:Humans; D016032:Randomized Controlled Trials as Topic
chemical_list: D005419:Flavonoids; C404987:flavan-3-ol